Zheng Quan Zhi Xing·2025-08-25 16:52Group 1 - The company, Kaineng Health Technology Group Co., Ltd., has received approval for the issuance of convertible bonds, which was passed by the board meeting on October 28, 2022, and the third extraordinary general meeting of shareholders on November 15, 2022 [2] - The convertible bonds are set to be issued to unspecified objects, with the registration approval from the China Securities Regulatory Commission dated June 17, 2023 [2] - The bonds will be valid from July 26, 2023, until July 19, 2029, with interest payments scheduled [2] Group 2 - The company has proposed a mid-term dividend plan for 2025, distributing cash dividends of RMB 0.8 per 10 shares, totaling approximately RMB 47.56 million based on the latest total share capital of 594,532,905 shares [3][4] - The dividend payout is expected to account for 67-70% of the net profit attributable to shareholders for the period [3] - The proposed dividend plan aligns with the company's profit distribution policy and is designed to share operational results with shareholders without adversely affecting the company's liquidity [4]